June 2021 in “Cosmoderma” This source reviews the latest developments in hair transplantation for androgenetic alopecia, suggesting that while medical therapy alone remains unsatisfactory, surgical hair restoration is shown to be highly gratifying for male pattern hair loss.
2 citations
,
March 2021 in “Cosmetics” This review highlights various treatment options for androgenetic alopecia, with a special focus on hair transplantation methods, discussing their benefits, drawbacks, and limitations as drawn from literature published from 1990 to the present.
7 citations
,
March 2020 in “Lasers in Medical Science” LLLT is a safe, promising hair loss treatment, but more research needed.
40 citations
,
July 2017 in “Frontiers in Medicine” This review highlights that in children, hair loss can be attributed to diverse conditions like alopecia areata and tinea capitis, and stresses the importance of a holistic approach to diagnosis and management, including psychosocial support due to limited effective treatments.
17 citations
,
August 2015 in “Expert Opinion on Pharmacotherapy” This article discusses the social and psychological impact of hair disorders and the challenges in their treatment, but reports no new clinical results.
February 2014 in “PubMed” This review reports that treatment recommendations for cicatricial alopecia remain challenging due to its rarity, unclear etiology, lack of a definitive therapy, and limited drug availability in Italy, while established regimens exist for other types of alopecia.
April 2010 in “Dermatology Times” November 2009 in “Dermatology Times” Low-level laser therapy is safe and effective for treating female hair loss.
This review discusses the causes, diagnosis, and potential treatments for androgenetic alopecia in women, presenting options for both systemic and topical therapies, but it reports no new clinical results.
22 citations
,
May 2000 in “American Journal of Clinical Dermatology” This review discusses treatment options for androgenetic alopecia in men and women, highlighting minoxidil and finasteride, without presenting new clinical findings.